Analyst Ken Trbovich from Janney Montgomery reiterated his buy rating for Depomed Inc (NASDAQ:DEPO) with a price target of $28, marking a 43% …
In a research note released this morning, Janney Montgomery Scott analyst Kimberly Lee reiterated coverage on Synageva BioPharma Corp. (GEVA) with a Buy rating and raised her fair value estimate …
